Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.54 USD | +0.88% | +2.08% | -48.59% |
May. 28 | Evoke Pharma, Inc. Appoints Mark A. Kowieski as Chief Financial Officer | CI |
May. 14 | Evoke Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.59% | 4.64M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- EVOK Stock
- News Evoke Pharma, Inc.
- Transcript : Evoke Pharma, Inc., Q3 2022 Earnings Call, Nov 09, 2022